A1 Resistance Is Fertile: The Coming of Age of AMR GC

Earn CE Credit for viewing the archived recordings of the 2012 STD Conference.

Deadline: April 12, 2014

For details, click Continuing Education Information

Tuesday, March 13, 2012: 10:15 AM-12:00 PM
Nicollet Grand Ballroom (C/D)

10:15 AM
RAPID ASSESSMENT and RESPONSE to Neisseria Gonorrhoeae with DECREASED SUSCEPTIBILITY to CEPHALOSPORINS In California
Carol Kong, MPH, Epidemiology and Surveillance Section, California Department of Public Health, STD Control Branch, Richmond, CA, Heidi Bauer, MD, MS, MPH, Sexually Transmitted Disease (STD) Control Branch, Division of Communicable Disease Control, Center for Infectious Diseases, California Department of Public Health, Richmond, CA, Ina Park, MD, MS, Sexually Transmitted Disease (STD) Control Branch, Division of Communicable Disease Control, Center for Infectious Diseases, Cal, California Department of Public Health, Richmond, CA, Mark Pandori, PhD, HCLD(ABB), Laboratory, San Francisco Department of Public Health Laboratory, San Francisco, CA, Kyle Bernstein, PhD, ScM, STD Prevention and Control Services Program, San Francisco Department of Public Health, San Francisco, CA, Ellen Rudy, PhD, STD Program, Los Angeles County Department of Public Health, Los Angeles, CA, Elaine Pierce, MD, HIV/STD/Hepatitis Branch, County of San Diego Health and Human Services Agency, San Diego, CA, Christopher Ried, MD, STD/HIV Services, Orange County Health Care Agency, Santa Ana, CA, Paula Dixon, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL, Olusegun Soge, PhD, Neisseria Reference Laboratory, University of Washington, Seattle, WA, Gail Bolan, MD, Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA and Michael Samuel, DrPH, California Department of Public Health, STD Control Branch, Richmond, CA
10:25 AM
Mandated Reporting of Neisseria Gonorrhoeae Antimicrobial Susceptibility Test Results to a Local Health Department to Surveil for the Emergence of Cephalosporin Resistance
Julia A. Schillinger, MD, MSc, Yi-Ci Shao, MS, Preeti Pathela, PhD and Susan Blank, MD, MPH, Bureau of STD Control and Prevention, New York City Department of Health and Mental Hygiene, New York, NY
10:35 AM
Gonorrhea Treatment Practices in the STD Surveillance Network (SSuN) in 2010
Roxanne Kerani, PhD, HIV/STD Control Program, Public Health - Seattle and King County, Seattle, WA, Mark Stenger, MA, DSTDP/Epidemiology & Surveillance Branch, CDC, Atlanta, GA, Hillard Weinstock, MD, MPH, Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA, Kyle Bernstein, PhD, ScM, STD Prevention and Control Services Program, San Francisco Department of Public Health, San Francisco, CA, Mary Reed, MPH, Colorado Dept. of Public Health and Environment, Denver, CO, Christina Schumacher, PhD, HIV/STD Prevention Program, Baltimore City Health Department, Baltimore, MD, Jane schwebke, MD, University of Alabama at Birmingham, Birmingham, AL and Matthew Golden, MD, MPH, Center for AIDS and STD, University of Washington, Seattle, WA
10:45 AM
Do New Ceftriaxone Treatment Recommendations for Gonorrhea Delay Treatment Among Low Injecting Facilities?
Binh Goldstein, PhD, Sarah Guerry, MD, Getahun Aynalem, MD, MPH and Peter Kerndt, MD, MPH, Sexually Transmitted Disease Program, Division of HIV/STD Programs, Los Angeles County Department of Public Health, Los Angeles, CA
10:55 AM
Failure of Azithromycin Treatment for Urogenital Gonorrhea in the United States Verified by Molecular Typing Methods
Olusegun Soge, PhD, Neisseria Reference Laboratory, University of Washington, Seattle, WA, Robert Kirkcaldy, MD, MPH, Division of STD Prevention, Centers for Disease Control and Prevention, Atlanta, GA, Sean Schafer, MD, Department of Human Services, Oregon Department of Health, Portland, OR, Doug Harger, BS, HIV/STD/TB Program, Oregon Public Health Division, Portland, OR and King Holmes, MD, PhD, Global Health, University of Washington, Seattle, WA
11:05 AM
Treatment in An Era of Dwindling Treatment Options
Kimberly Workowski, MD, Division of Infectious Diseases, Emory University, atlanta, GA
See more of: Oral and Poster